Sector: MedicalCuraGen Corporation (NASDAQ: CRGN)
Headlines
- Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts
Oct 19, 2009 10:24 PM | BMY, CLDA, CRGN, GSK, MEDX
- Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board
Sep 17, 2009 07:30 AM | AZN, BAY, CRGN
- Curagen (NasdaqGM: CRGN)– Positive Results At ASCO 2009
Jul 07, 2009 09:30 AM | CRGN, IMGN, SGEN
- Top Picks For ASCO 2009
May 26, 2009 07:49 AM | ARIA, ARQL, BMY, CEPH, CRGN, EXEL
- Spicing Up The Biotech Portfolio - Curagen and Curis
Feb 24, 2009 08:00 PM | CLDA, CRGN, CRIS, CRXL, DNA, NVS
- Immunogen at ASCO Annual Meeting 2008
Jul 15, 2008 08:41 AM | CRGN, DNA, IMGN, SGEN, SNTA, SNY
- CuraGen Risk/Reward Balanced
Jun 24, 2008 02:09 PM | CRGN
- Immunogen and Seattle Genetics – On The Verge Of An Inflection Point
May 24, 2008 12:35 PM | ADC, CLDA, CRGN, DNA, IMGN, MITI
- NASDAQ Technical Picture - Narrow Range Consolidation - May 23 2008 1:56AM
May 23, 2008 01:56 AM | AACC, ALKS, ARO, ARUN, BBOX, BFAM
- Analyst Comments: Altera, Texas Capital, CuraGen, Solar Panel Stocks
Apr 17, 2008 06:48 PM | ALTR, CHRT, CRGN, CY, SMI, TCBI
- Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation
Oct 01, 2009 02:51 PM | CRGN, PFE
- Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation
Sep 30, 2009 06:52 PM | CRGN, PFE
- Celldex Therapeutics Announces Appointment of Larry Ellberger As Chairman of the Board
Sep 04, 2009 04:51 PM | CRGN, GRA, JNJ, PDII, PFE
- Celldex Reports Second Quarter and Six Month 2009 Financial Results
Aug 05, 2009 07:52 AM | AMGN, CRGN, PFE
- CuraGen Reports Second Quarter 2009 Financial Results
Jul 31, 2009 06:50 AM | CRGN
- CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
Jun 17, 2009 06:31 AM | CRGN
- CuraGen Updates CR011-vcMMAE Data at ASCO
Jun 02, 2009 06:30 AM | CRGN
- Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
May 29, 2009 06:54 AM | CRGN
- CuraGen to Present CR011-vcMMAE Data at ASCO
May 28, 2009 06:30 AM | CRGN
- /C O R R E C T I O N -- CuraGen Corporation/
Apr 23, 2009 12:54 PM | CRGN
- Form 4/A SHANNON TIMOTHY M For: Oct 01 (10K)
Oct 06, 2009 06:58 PM
- Form 4/A Finigan Paul M For: Oct 01 (10K)
Oct 06, 2009 06:55 PM
- Form 4/A Cassidy Sean A For: Oct 01 (10K)
Oct 06, 2009 06:53 PM
- Form 4/A CURAGEN CORP For: Oct 01 Filed by: ZENNER PATRICK J (10K)
Oct 06, 2009 06:52 PM
- Form 4/A PATRICELLI ROBERT E For: Oct 01 (10K)
Oct 06, 2009 06:52 PM
- Form 4/A Noble James For: Oct 01 (10K)
Oct 06, 2009 06:50 PM
- Form 4/A FORSGREN JOHN H For: Oct 01 (10K)
Oct 06, 2009 06:49 PM
- Form 4/A CURAGEN CORP For: Oct 01 Filed by: DEVITA VINCENT (10K)
Oct 06, 2009 06:49 PM
- Form 4 SHANNON TIMOTHY M For: Oct 01 (10K)
Oct 05, 2009 06:10 PM
- Form 4 Finigan Paul M For: Oct 01 (10K)
Oct 05, 2009 06:05 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CRGN
|
Compare to S&P
|
| YTD |
180.43 %
|
142.54 %
|
| 4 Weeks |
-5.84 %
|
-7.23 %
|
| 12 Weeks |
-9.15 %
|
-22.02 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -60.00 %
|
|
EPS Growth in Last Year: -14.29 %
|
|
Sales Growth in Last Quarter: 5,136.36 %
|
|
Sales Growth in Last Quarter: 5,136.36 %
|
|
